Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: a meta-review of systematic reviews and an updated meta-analysis

View ORCID ProfileTawanda Chivese, Omran A. H. Musa, George Hindy, Noor Al-Wattary, Saif Badran, Nada Soliman, Ahmed T. M. Aboughalia, Joshua T. Matizanadzo, Mohamed M. Emara, Lukman Thalib, Suhail A. R. Doi
doi: https://doi.org/10.1101/2020.07.28.20164012
Tawanda Chivese
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tawanda Chivese
  • For correspondence: tchivese{at}qu.edu.qa
Omran A. H. Musa
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hindy
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noor Al-Wattary
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saif Badran
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
2Hamad General Hospital, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nada Soliman
3College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed T. M. Aboughalia
3College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua T. Matizanadzo
4Brighton and Sussex Medical School, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed M. Emara
5Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar
6Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukman Thalib
7Department of Biostatistics, Faculty of Medicine, Istanbul Aydin University, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suhail A. R. Doi
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19, and to update the evidence using a meta-analysis.

Methods A comprehensive search was carried out in electronic databases for systematic reviews, meta-analyses and experimental studies which investigated the efficacy and safety of CQ, HCQ with or without Azithromycin to treat COVID-19. Findings from the reviews were synthesised using tables and forest plots and the quality effect model was used for the updated meta-analysis. The main outcomes were mortality, the need for intensive care services, disease exacerbation, viral clearance and occurrence of adverse events.

Results Thirteen reviews with 40 primary studies were included. Two meta-analyses reported a high risk of mortality, with ORs of 2.2 and 3.0, and the two others found no association between HCQ and mortality. Findings from two meta-analyses showed that HCQ with Azithromycin increased the risk of mortality, with similar ORs of 2.5. The updated meta-analysis of experimental studies showed that the drugs were not effective in reducing mortality (RR 1.1, 95%CI 1.0-1.3, I2 =0.0%), need for intensive care services (OR 1.1, 95%CI 0.9-1.4, I2 =0.0%), virological cure (OR 1.5, 95%CI 0.5-4.4, I2 =39.6%) or disease exacerbation (OR 1.2, 95%CI 0.3-5.9, I2 =31.9%) but increased the odds of adverse events (OR 12,3, 95%CI 2.5-59.9, I2 =76.6%).

Conclusion There is conclusive evidence that CQ and HCQ, with or without Azithromycin are not effective in treating COVID-19 or its exacerbation.

Registration PROSPERO: CRD42020191353

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The is no funding to report

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB approval was required

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • A revised version after peer review has been uploaded

Data Availability

Data are available upon request

  • Abbreviations

    COVID-19
    Coronavirus Disease-19
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    HCQ
    hydroxychloroquine,
    CQ
    chloroquine
    PRIO-harms
    Preferred Reporting Items for Overviews of Systematic Reviews including harms checklist
    AMSTAR
    Assessing the Methodological Quality of Systematic Reviews
    MASTER
    MethodologicAl STandard for Epidemiological Research
    PRISMA
    Preferred Reporting Items for Systematic Review and Meta-Analysis
    CDSR
    Cochrane Database of Systematic Reviews
    CENTRAL
    Cochrane Central Register of Controlled Trials
    DARE
    Database of Abstracts of Reviews of Effectiveness
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 09, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: a meta-review of systematic reviews and an updated meta-analysis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: a meta-review of systematic reviews and an updated meta-analysis
    Tawanda Chivese, Omran A. H. Musa, George Hindy, Noor Al-Wattary, Saif Badran, Nada Soliman, Ahmed T. M. Aboughalia, Joshua T. Matizanadzo, Mohamed M. Emara, Lukman Thalib, Suhail A. R. Doi
    medRxiv 2020.07.28.20164012; doi: https://doi.org/10.1101/2020.07.28.20164012
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: a meta-review of systematic reviews and an updated meta-analysis
    Tawanda Chivese, Omran A. H. Musa, George Hindy, Noor Al-Wattary, Saif Badran, Nada Soliman, Ahmed T. M. Aboughalia, Joshua T. Matizanadzo, Mohamed M. Emara, Lukman Thalib, Suhail A. R. Doi
    medRxiv 2020.07.28.20164012; doi: https://doi.org/10.1101/2020.07.28.20164012

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (433)
    • Allergy and Immunology (758)
    • Anesthesia (222)
    • Cardiovascular Medicine (3308)
    • Dentistry and Oral Medicine (365)
    • Dermatology (282)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1174)
    • Epidemiology (13391)
    • Forensic Medicine (19)
    • Gastroenterology (900)
    • Genetic and Genomic Medicine (5168)
    • Geriatric Medicine (482)
    • Health Economics (783)
    • Health Informatics (3282)
    • Health Policy (1144)
    • Health Systems and Quality Improvement (1197)
    • Hematology (432)
    • HIV/AIDS (1021)
    • Infectious Diseases (except HIV/AIDS) (14647)
    • Intensive Care and Critical Care Medicine (914)
    • Medical Education (478)
    • Medical Ethics (128)
    • Nephrology (525)
    • Neurology (4941)
    • Nursing (262)
    • Nutrition (733)
    • Obstetrics and Gynecology (887)
    • Occupational and Environmental Health (796)
    • Oncology (2526)
    • Ophthalmology (730)
    • Orthopedics (284)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (546)
    • Pediatrics (1304)
    • Pharmacology and Therapeutics (551)
    • Primary Care Research (557)
    • Psychiatry and Clinical Psychology (4221)
    • Public and Global Health (7522)
    • Radiology and Imaging (1710)
    • Rehabilitation Medicine and Physical Therapy (1016)
    • Respiratory Medicine (981)
    • Rheumatology (480)
    • Sexual and Reproductive Health (499)
    • Sports Medicine (425)
    • Surgery (550)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (206)